| Firm |
Analyst |
| Argus Research Company |
Jacob Kilstein |
| Bank of America Merrill Lynch |
Jason Gerberry |
| Barclays |
Balaji Prasad |
| BMO Capital |
Gary Nachman |
| BTIG |
Timothy Chiang |
| Cantor Fitzgerald |
Louise Chen |
| Citi |
Navann Ty |
| Cowen And Company |
Ken Cacciatore |
| Evercore ISI |
Umer Raffat |
| Gabelli & Company |
Kevin Kedra |
| Guggenheim Securities |
Dana Flanders |
| HSBC |
Stephen McGarry |
| Israel Firmage & Investments (IBI) |
Steven Tepper |
| Jefferies & Co. |
David Steinberg |
| JPMorgan |
Christopher T. Schott |
| Leerink Partners |
Ami Fadia |
| Meitav Dash Firmage |
Jonathan Kreizman |
| Morgan Stanley |
David Risinger |
| Morningstar, Inc. |
Soo Ramanoff |
| Oppenheimer & Co. |
Esther Rajavelu |
| Piper Jaffray |
David A. Amsellem |
| Raymond James |
Elliot Wilbur |
| RBC Capital Markets |
Randall Stanicky |
| Sanford C. Bernstein & Co., LLC |
Ronny Gal |
| SunTrust Robinson Humphry |
Gregg Gilbert |
| UBS (US) |
Kevin Caliendo |
| Wells Fargo |
Jacob Hughes |
| Wolf Research |
Akash Tewari |
Teva Pharmaceutical Industries Ltd. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Teva Pharmaceutical Industries Ltd.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Teva Pharmaceutical Industries Ltd. or its management. Teva Pharmaceutical Industries Ltd. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.